Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement

Bor Sheng Ko; Cheng Shyong Chang; Ming Chih Chang; Tsai Yun Chen; Tzeon Jye Chiou; Chang Fang Chiu; Wen Li Huang; Woei Yau Kao; Yii Jenq Lan; Shen Fung Lin; Tran Der Tan; Jih Luh Tang; Cheng Hwai Tzeng; Po Nan Wang; Su Pen Yet; Hwei Fang Tien

doi:10.1007/s12185-014-1607-x

Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement

Bor Sheng Ko, Cheng Shyong Chang, Ming Chih Chang, Tsai Yun Chen, Tzeon Jye Chiou, Chang Fang Chiu, Wen Li Huang, Woei Yau Kao, Yii Jenq Lan, Shen Fung Lin, Tran Der Tan, Jih Luh Tang, Cheng Hwai Tzeng, Po Nan Wang, Su Pen Yet, Hwei Fang Tien

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Abstract

Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

Original language	English
Pages (from-to)	7-15
Number of pages	9
Journal	International Journal of Hematology
Volume	100
Issue number	1
DOIs	https://doi.org/10.1007/s12185-014-1607-x
Publication status	Published - Jul 2014
Externally published	Yes

Keywords

Ferritin
Guidelines
ICT
Iron overload
MDS
Taiwan

ASJC Scopus subject areas

Hematology

Access to Document

10.1007/s12185-014-1607-x

Cite this

Ko, B. S., Chang, C. S., Chang, M. C., Chen, T. Y., Chiou, T. J., Chiu, C. F., Huang, W. L., Kao, W. Y., Lan, Y. J., Lin, S. F., Tan, T. D., Tang, J. L., Tzeng, C. H., Wang, P. N., Yet, S. P., & Tien, H. F. (2014). Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement. International Journal of Hematology, 100(1), 7-15. https://doi.org/10.1007/s12185-014-1607-x

@article{b39f7fd923ec4997bd9331ca55ac563a,

title = "Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement",

abstract = "Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.",

keywords = "Ferritin, Guidelines, ICT, Iron overload, MDS, Taiwan",

author = "Ko, {Bor Sheng} and Chang, {Cheng Shyong} and Chang, {Ming Chih} and Chen, {Tsai Yun} and Chiou, {Tzeon Jye} and Chiu, {Chang Fang} and Huang, {Wen Li} and Kao, {Woei Yau} and Lan, {Yii Jenq} and Lin, {Shen Fung} and Tan, {Tran Der} and Tang, {Jih Luh} and Tzeng, {Cheng Hwai} and Wang, {Po Nan} and Yet, {Su Pen} and Tien, {Hwei Fang}",

note = "Funding Information: T.-D. Tan Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan Funding Information: Conflict of interest The expert panel meetings and article writing are all sponsored by the Hematology Society of Taiwan. No other potential conflicts of interest are disclosed for the authors.",

year = "2014",

month = jul,

doi = "10.1007/s12185-014-1607-x",

language = "English",

volume = "100",

pages = "7--15",

journal = "International Journal of Hematology",

issn = "0925-5710",

publisher = "Springer Japan",

number = "1",

}

TY - JOUR

T1 - Guidelines for treating iron overload in myelodysplastic syndromes

T2 - A Taiwan consensus statement

AU - Ko, Bor Sheng

AU - Chang, Cheng Shyong

AU - Chang, Ming Chih

AU - Chen, Tsai Yun

AU - Chiou, Tzeon Jye

AU - Chiu, Chang Fang

AU - Huang, Wen Li

AU - Kao, Woei Yau

AU - Lan, Yii Jenq

AU - Lin, Shen Fung

AU - Tan, Tran Der

AU - Tang, Jih Luh

AU - Tzeng, Cheng Hwai

AU - Wang, Po Nan

AU - Yet, Su Pen

AU - Tien, Hwei Fang

N1 - Funding Information: T.-D. Tan Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan Funding Information: Conflict of interest The expert panel meetings and article writing are all sponsored by the Hematology Society of Taiwan. No other potential conflicts of interest are disclosed for the authors.

PY - 2014/7

Y1 - 2014/7

N2 - Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

AB - Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

KW - Ferritin

KW - Guidelines

KW - ICT

KW - Iron overload

KW - MDS

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=84904309011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904309011&partnerID=8YFLogxK

U2 - 10.1007/s12185-014-1607-x

DO - 10.1007/s12185-014-1607-x

M3 - Review article

C2 - 24924953

AN - SCOPUS:84904309011

SN - 0925-5710

VL - 100

SP - 7

EP - 15

JO - International Journal of Hematology

JF - International Journal of Hematology

IS - 1

ER -

Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this